{"transactions":[{"id":3097780,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":148209,"kind":"person","name":"Banham John Michael Middlecott","position":1,"cik":"0001357635","reported_name":"Banham John Michael Middlecott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-29T22:51:06.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were granted to Sir John Banham for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":5200,"derivative":{"exercise_price":4.7,"exercise_date":"2021-06-25","expiration_date":"2030-06-25","underlying":"Common Stock","underlying_shares":5200},"source":{"system":"sec-edgar","filing":"0001104659-20-078131","document":"tm2023597-7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465920078131/tm2023597-7_4.xml","form_type":"4"}},{"id":3506525,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":148209,"kind":"person","name":"Banham John Michael Middlecott","position":1,"cik":"0001357635","reported_name":"Banham John Michael Middlecott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-31T20:39:33.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were granted to Sir John Banham for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":18750,"derivative":{"exercise_price":0.64,"exercise_date":"2020-05-29","expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001144204-19-029259","document":"tv522825_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000114420419029259/tv522825_form4.xml","form_type":"4"}},{"id":3908774,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":148209,"kind":"person","name":"Banham John Michael Middlecott","position":1,"cik":"0001357635","reported_name":"Banham John Michael Middlecott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-04T21:33:42.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":8576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were granted to Sir John Banham for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":8576,"derivative":{"exercise_price":1.42,"exercise_date":"2019-05-31","expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":8576},"source":{"system":"sec-edgar","filing":"0001144204-18-032718","document":"tv495789_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000114420418032718/tv495789_form4.xml","form_type":"4"}},{"id":4298302,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":148209,"kind":"person","name":"Banham John Michael Middlecott","position":1,"cik":"0001357635","reported_name":"Banham John Michael Middlecott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-01T21:03:53.000Z","date":"2017-05-30","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were granted to Sir John Banham for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":2000,"derivative":{"exercise_price":4.38,"exercise_date":"2018-05-30","expiration_date":"2027-05-30","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001571049-17-005583","document":"t1701732_x1-f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000157104917005583/t1701732_x1-f4.xml","form_type":"4"}}]}